Epilobium parviflorum (Épilobe) : vertus médicinales en extraction alcoolique

Epilobium parviflorum (Épilobe, Fireweed) — famille Onagracées.

Synonymes scientifiques : Chamaenerion parviflorum-Schreb, Epilobium mollissimum-Schur, E pubescens-Roth, E rivulare-H, E uralense-H, E villosum-C.

Cette base documente les extractions alcooliques (éthanol) des substances actives. Notre monographie recense actuellement 4 indications en extraction alcoolique pour cette espèce. Le catalogue Lapo v2 enregistre 21 références scientifiques pour cette espèce (détail intégral dans l’application).

Important — références scientifiques sur cette page publique : seuls de courts extraits de chaque source citée sont présentés (phrases d’abstract sélectionnées), conservés dans leur langue d’origine (le plus souvent l’anglais), sans traduction. Ces extraits ne constituent pas le texte intégral de l’article ni une bibliographie complète. Les fiches de référence complètes et le détail monographique sont disponibles dans l’application Lapo v2 (essai gratuit 30 jours).

1. 1

   Cancer : traitement adjuvant du carcinome colorectal

   Partie usitée : Semence.

   Références scientifiques (courts extraits)

   Courts extraits uniquement (pas le texte intégral de l’article). Fiches de référence complètes dans l’application Lapo v2.

   • Selon AKBUDAk A A (2002)

     Extrait The present study exhibited the antiproliferative activity of aqueous & ethanolic Epilobium parviflorum extracts in a colon cancer cell line, HT-29 cells in vitro. Although their benefits have been demonstrated on certain types of cancer cells, such as prostate cancer cells, their potential antiproliferative effects on colorectal adenocarcinoma cells have yet to be studied.

   • Selon Hatefi Kia B (2021)

     Extrait Conclusion: This study is the first to demonstrate that Epilobium parviflorum had a strong growth inhibiting property on MCF-7 cell line, as a potential model to treat human breast cancer cells. Epilobium parviflorum extracts have shown promising therapeutic effects on prostate cancer cells.

   • Selon Auteur (2019)

     Extrait While reviewing the literature; we did not encounter any studies that practised the expression of apoptotic genes which is applied to the colon cancer cell line (HT29) & fibroblast cell line (BJ) of Epilobium parviflorum.

   • Selon Stolarczyk M (2013)

     Extrait Our studies demonstrated that the extracts from Epilobium angustifolium, Epilobium parviflorum & Epilobium hirsutum herbs are potent prostate cancer cells (LNCaP) proliferation inhibitors with IC50 values around 35 µg/ml. Results of the work offer an explanation of the activity of Epilobium extracts & support the use of Epilobium preparations in the treatment of prostate diseases.

   • Selon Stolarczyk M (2013)

     Extrait Conclusions: This study demonstrated that Epilobium extracts are active against LNCaP prostate cancer cells & that their apoptotic activity is related to activation of the mitochondrial pathway. The aim of this work was to determine the effect of standardized aqueous extracts from Epilobium angustifolium L., E.

2. 2

   État inflammatoire : arthrose, arthrite, rhumatisme, oedème

   Partie usitée : Feuille.

   Références scientifiques (courts extraits)

   Courts extraits uniquement (pas le texte intégral de l’article). Fiches de référence complètes dans l’application Lapo v2.

   • Selon Hevesi BT (2009)

     Extrait parviflorum with respect to its antioxidant and antiinflammatory effects. Epilobium parviflorum Schreb.

   • Selon Granica S (2014)

     Extrait were shown to possess antimicrobial, anti-proliferative, anti-inflammatory, analgesic & antioxidative activities. As far as the treatment of benign prostate hyperplasia (BPH) is considered, in the literature, there are some reports indicating that Epilobium extracts have a beneficial effect for this disorder, but the number of in vitro studies is not sufficient & the in vivo studies are not conclusive or too preliminary to draw a final conclusion about the efficacy of Epilobium preparations.

   • Selon Merighi S (2021)

     Extrait We investigated the phenolic content characterizing different plant extracts from Epilobium parviflorum, Cardiospermum halicacabum, & Melilotus officinalis, their antioxidant, antiinflammatory effects, & their mechanism of action. Conclusion: EP, CH, & MO extracts may be considered a source of agents for treating disorders related to oxidative stress & inflammation.

   • Selon Hiermann A (1986)

     Extrait Epilobium species have been used as remedies in folk-medicine for the treatment of pathophysiological processes of the prostata. angustifolium strongly reduced the carrageenin-induced rat paw oedema whereas that of E.

   • Selon Tóth B Hevesi (2009)

     Extrait Both the water & ethanol extracts of Hypoxis hemerocallidea & Epilobium parviflorum inhibited the growth of Escherichia coli. In vitro studies have been made to investigate different aspects of its antioxidant capacity, anti-inflammatory (COX-inhibitory) action, steroid-receptor -agonistic & -antagonistic effect as well as aromatase-inhibitory effect.

3. 3

   Prostatisme bénin, hyperplasie bégnine de la prostate

   Partie usitée : Feuille.

   Références scientifiques (courts extraits)

   Courts extraits uniquement (pas le texte intégral de l’article). Fiches de référence complètes dans l’application Lapo v2.

   • Selon AKBUDAk A A (2002)

     Extrait The Epilobium species are rich in various active phytochemicals & have seen wide use in folk medicine to treat several diseases, including benign prostatic hyperplasia. The present study exhibited the antiproliferative activity of aqueous & ethanolic Epilobium parviflorum extracts in a colon cancer cell line, HT-29 cells in vitro.

   • Selon Vitalone A (s.d.)

     Extrait This study examined whether various species of Epilobium, a phytotherapeutic agent used in folk medicine as a treatment for benign prostatic hyperplasia, may have an antiproliferative effect in PZ-HPV-7 human prostatic epithelial cells in-vitro. This study provides some initial biological plausibility for the use of Epilobium extracts in benign prostatic hyperplasia.

   • Selon Hevesi BT (2009)

     Extrait (Onagraceae) is used for the treatment of benign prostatic hyperplasia (BPH), but its biological action is not entirely identified. Epilobium parviflorum Schreb.

   • Selon Vitalone A (s.d.)

     Extrait We have previously shown that extracts of different Epilobium species, a phytotherapeutic agent used in folk medicine as a treatment for benign prostatic hyperplasia, inhibit proliferation of human prostate cells. These results indicate that Epilobium extracts inhibit proliferation of prostate cells in a nonspecific manner.

   • Selon Tóth B Hevesi (2009)

     Extrait Epilobium parviflorum is used for the treatment of benign prostatic hyperplasia (BPH), but its biological action is not entirely identified. -Abstract: Crude water & ethanolic extracts of five herbal remedies reported in the literature for traditional treatment of benign prostatic hyperplasia (BPH) and/or prostatitis were investigated for their effect on hydroxyl scavenging activity, antibacterial activity & their ability to inhibit cyclooxygenase-1 & -2 (COX-1 & COX-2) catalysed prostaglandin biosynthesis.

D’autres indications (y compris d’autres modes d’extraction le cas échéant), posologies, précautions d’emploi et les <strong>références scientifiques complètes</strong> (fiches intégrales, pas seulement les courts extraits ci-dessus) sont disponibles dans la fiche monographique de l’application Lapo v2.